Exclusive-Warburg and Advent in the lead to acquire Baxter’s biopharma unit-sources
By David Carnevali and Anirban Sen NEW YORK (Reuters) -A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc’s biopharma solutions business in a deal that could reach or exceed $4 billion, people familiar with the matter said on Sunday. Warburg Pincus and Advent have submitted the most attractive offer to Baxter in an auction that drew interest […]